Monosialoganglioside-Containing Nanoliposomes Restore Endothelial Function Impaired by AL Amyloidosis Light Chain Proteins. [electronic resource]
Producer: 20180102ISSN:- 2047-9980
- Adipose Tissue -- blood supply
- Arterioles -- drug effects
- Cell Survival -- physiology
- Cholesterol -- administration & dosage
- Drug Combinations
- Endothelial Cells -- metabolism
- Endothelium, Vascular -- drug effects
- Gangliosides -- administration & dosage
- Gene Knockdown Techniques -- methods
- Human Umbilical Vein Endothelial Cells
- Humans
- Immunoglobulin Light-chain Amyloidosis -- complications
- Male
- Middle Aged
- NAD(P)H Dehydrogenase (Quinone) -- genetics
- NF-E2-Related Factor 2 -- genetics
- Nanoparticles -- administration & dosage
- Nitric Oxide -- physiology
- Nitric Oxide Synthase Type III -- metabolism
- Papaverine -- pharmacology
- Peroxynitrous Acid -- biosynthesis
- Phosphatidylcholines -- administration & dosage
- RNA Interference -- physiology
- RNA, Small Interfering -- physiology
- Reactive Oxygen Species -- metabolism
- Superoxides -- metabolism
- Transfection
- Vascular Diseases -- physiopathology
- Vasodilator Agents -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.